Table 4.
Evaluation of symptoms relief.
Treatment | n (%) | Within the First Week of Intake | Within 2 Weeks of Intake | After More than 2 Weeks of Intake | No Improvement |
---|---|---|---|---|---|
µsmin® Plus | 37 (100) | 4 (10.81) | 25 (67.57) | 7 (18.92) | 1 (2.70) |
Placebo | 35 (100) | 0 | 4 (11.43) | 6 (17.14) | 25 (71.43) |